Drug Trial Radar · NCT07610837
Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis
Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
104
Planned (sponsor's estimate)
Start
May 7, 2026
Primary completion
Jul 7, 2027
Study completion Jul 7, 2027
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- May 28, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety, tolerability, and pharmacodynamic effects of AZD2389 in adult participants with steatotic liver disease (SLD) and advanced fibrosis.
Conditions
- Liver Fibrosis
- Hepatic Cirrhosis
Interventions
AZD2389Drug
potent, selective, first-in-class, small molecule oral inhibitor of FAP and is being developed for the treatment of CLDs with advanced hepatic fibrosis including cirrhosis.
PlaceboOther
Oral administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Absolute change in Enhanced Liver Fibrosis (ELF) score from baseline to week 24Time frame: 24 weeks
- Reported quantity and severity of adverse events (AEs)Time frame: Up to and including Day 197
- Number of participants with observed changes in blood pressure against baseline mmHg valueTime frame: Up to and including Day 197
- Number of participants with identified abnormalities in results of 12-lead safety electrocardiograms (ECG)Time frame: Up to and including Day 197
- Number of participants with abnormal laboratory results detected in urine samplesTime frame: Up to and including Day 197
- Number of participants with observed changes in heart rate (BPM) against baseline valueTime frame: Up to and including Day 197
- Number of participants with observed changes in Sp02 oxygen values against baseline measurementTime frame: Up to and including Day 197
- Number of participants with observed changes in body temperature against baseline valueTime frame: Up to and including Day 197
- Number of participants with observed changes in respiratory rate against baseline valueTime frame: Up to and including Day 197
- Number of participants with abnormal laboratory test results detected in blood samplesTime frame: Up to and including Day 197
- Number of participants with abnormal laboratory test results detected in blood samplesTime frame: Up to and including Day 197
- Number of participants with abnormal laboratory test results detected in blood samplesTime frame: Up to and including Day 197
- Number of participants with abnormal laboratory test results detected in blood samplesTime frame: Up to and including Day 197
- Number of participants with abnormal laboratory test results detected in blood samplesTime frame: Up to and including Day 197
- Number of participants with abnormal laboratory test results detected in blood samplesTime frame: Up to and including Day 197
Locations
22 sites in 2 countries. Site status is shown where the registry gives one.
Research Site
Chandler, Arizona · Recruiting
Research Site
Tucson, Arizona · Recruiting
Research Site
Fresno, California · Recruiting
Research Site
Jupiter, Florida · Recruiting
Research Site
Miami, Florida · Recruiting
Research Site
Port Orange, Florida · Recruiting
Research Site
Kansas City, Missouri · Recruiting
Research Site
St Louis, Missouri · Recruiting
Research Site
Las Vegas, Nevada · Recruiting
Research Site
Morehead City, North Carolina · Recruiting
Research Site
Raleigh, North Carolina · Recruiting
Research Site
Westlake, Ohio · Recruiting
Research Site
Yukon, Oklahoma · Recruiting
Research Site
Clarksville, Tennessee · Recruiting
Research Site
Austin, Texas · Recruiting
Research Site
Denison, Texas · Recruiting
Research Site
Georgetown, Texas · Recruiting
Research Site
Houston, Texas · Recruiting
Research Site
Houston, Texas · Recruiting
Research Site
San Antonio, Texas · Recruiting
Research Site
San Antonio, Texas · Recruiting
Research Site
San Juan, Puerto Rico · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.